{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:11:31Z","timestamp":1793722291722,"version":"4.6.1"},"reference-count":241,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021778","name":"National Agency for the Promotion of Research Technological Development and Innovation","doi-asserted-by":"publisher","award":["PICT-GR-150"],"award-info":[{"award-number":["PICT-GR-150"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fund for Scientific and Technological Research","doi-asserted-by":"publisher","award":["PICT-INVI-282"],"award-info":[{"award-number":["PICT-INVI-282"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bmcl.2025.130305","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:05:10Z","timestamp":1749405910000},"page":"130305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Fighting Alzheimer's naturally: Peptides as multitarget drug leads"],"prefix":"10.1016","volume":"127","author":[{"given":"Roque","family":"Spinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sanch\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Siano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130305_bb0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuroimage.2018.11.024","article-title":"Disease progression timeline estimation for Alzheimer\u2019s disease using discriminative event based modeling","volume":"186","author":"Venkatraghavan","year":"2019","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/CON.0000000000000687","article-title":"Early-onset Alzheimer disease and its variants","volume":"25","author":"Mendez","year":"2019","journal-title":"Continuum (Minneapolis, Minn)"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb0015","first-page":"S177","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.bmcl.2025.130305_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ejmech.2018.05.004","article-title":"A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer\u2019s disease","volume":"152","author":"Jalili-Baleh","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0025","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acsomega.4c05527","article-title":"Newer therapeutic approaches in treating Alzheimer\u2019s disease: A comprehensive review","volume":"10","author":"Reddi Sree","year":"2025","journal-title":"ACS omega"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130305_bb0030","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1523\/JNEUROSCI.4647-06.2007","article-title":"Functional characterization of intrinsic cholinergic interneurons in the cortex","volume":"27","author":"von Engelhardt","year":"2007","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"issue":"4558","key":"10.1016\/j.bmcl.2025.130305_bb0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pbb.2011.02.022","article-title":"The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation","volume":"99","author":"Dumas","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bmcl.2025.130305_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnmol.2012.00101","article-title":"Acetylcholinesterase: old questions and new developments","volume":"5","author":"Tsim","year":"2013","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bmcl.2025.130305_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2011.00019","article-title":"Interactions of AChE with a\u03b2 aggregates in Alzheimer\u2019s brain: therapeutic relevance of IDN 5706","volume":"4","author":"Carvajal","year":"2011","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/biom10010040","article-title":"Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement","volume":"10","author":"Stanciu","year":"2019","journal-title":"Biomolecules"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb0070","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.3390\/molecules26164895","article-title":"Synthesis, biological evaluation, and in silico studies of new acetylcholinesterase inhibitors based on Quinoxaline scaffold","volume":"26","author":"Suwanhom","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130305_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2009.08.014","article-title":"An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon","volume":"241","author":"Shenouda","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb0085","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"5022","key":"10.1016\/j.bmcl.2025.130305_bb0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"issue":"1\u20133","key":"10.1016\/j.bmcl.2025.130305_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem Biol Interact"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130305_bb0100","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1021\/jm901853b","article-title":"Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation","volume":"53","author":"Carletti","year":"2010","journal-title":"J Med Chem"},{"issue":"Pt 11","key":"10.1016\/j.bmcl.2025.130305_bb0105","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1107\/S0907444900010659","article-title":"Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II","volume":"56","author":"Kryger","year":"2000","journal-title":"Acta crystallogr D Biol crystallogr"},{"issue":"22","key":"10.1016\/j.bmcl.2025.130305_bb0110","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J Med Chem"},{"issue":"42","key":"10.1016\/j.bmcl.2025.130305_bb0115","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1021\/ar010025i","article-title":"Molecular dynamics of acetylcholinesterase","volume":"35","author":"Shen","year":"2002","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmcl.2025.130305_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151374","article-title":"In silico exploration of cholinergic activity and neuroprotection of novel caffeine analogues","volume":"750","author":"Obiol","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0130","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.3390\/ijms14035608","article-title":"Structure-based search for new inhibitors of cholinesterases","volume":"14","author":"Bajda","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/biom11040580","article-title":"A comprehensive review of cholinesterase modeling and simulation","volume":"11","author":"De Boer","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb0140","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/bi962484a","article-title":"Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase","volume":"36","author":"Masson","year":"1997","journal-title":"Biochemistry"},{"issue":"29","key":"10.1016\/j.bmcl.2025.130305_bb0145","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1021\/bi980536l","article-title":"Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF","volume":"37","author":"Nachon","year":"1998","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study","volume":"Vol. 22","author":"Rosenberry","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0155","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1529\/biophysj.108.129601","article-title":"Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics","volume":"95","author":"Xu","year":"2008","journal-title":"Biophys J"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138161206775193127","article-title":"The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design","volume":"12","author":"Johnson","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0165","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/14756366.2018.1476502","article-title":"Identification of new allosteric sites and modulators of AChE through computational and experimental tools","volume":"33","author":"Roca","year":"2018","journal-title":"J enz inhib med chem"},{"issue":"25","key":"10.1016\/j.bmcl.2025.130305_bb0170","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1021\/ja0512780","article-title":"The role of the peripheral anionic site and cation\u2212\u03c0 interactions in the ligand penetration of the human AChE gorge","volume":"127","author":"Branduardi","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130305_bb0175","article-title":"QSAR Models towards Cholinesterase Inhibitors for the Treatment of Alzheimer\u2019s Disease","author":"Mohan","year":"2017","journal-title":"IGI Global Sci Pub Res"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/psc.2974","article-title":"Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes","volume":"23","author":"Siano","year":"2017","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bmcl.2025.130305_bb0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tifs.2021.04.056","article-title":"Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review","volume":"116","author":"Wang","year":"2021","journal-title":"Trends Food Sci Technol"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(01)00730-0","article-title":"Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat","volume":"412","author":"Yamaguchi","year":"2001","journal-title":"E j pharmacol"},{"key":"10.1016\/j.bmcl.2025.130305_bb0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/0-387-23226-5_15","article-title":"Acetylcholinesterase interaction with Alzheimer amyloid beta","volume":"38","author":"Inestrosa","year":"2005","journal-title":"Subcell Biochem"},{"issue":"5\u20136","key":"10.1016\/j.bmcl.2025.130305_bb0200","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0928-4257(99)80002-3","article-title":"Molecular interactions of acetylcholinesterase with senile plaques","volume":"92","author":"Inestrosa","year":"1998","journal-title":"J Physiol Paris"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130305_bb0205","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer\u2019s fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130305_bb0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130305_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234410","article-title":"Future therapeutic perspectives into the Alzheimer\u2019s disease targeting the oxidative stress hypothesis","volume":"24","author":"Teixeira","year":"2019","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.bmcl.2025.130305_bb0225","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4103\/0366-6999.220313","article-title":"Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of Alzheimer\u2019s disease","volume":"130","author":"Wu","year":"2017","journal-title":"Chin Med J"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0230","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark","year":"2003","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130305_bb0235","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.3390\/molecules23092335","article-title":"Novel protein kinase inhibitors related to tau pathology modulate tau protein-self interaction using a luciferase complementation assay","volume":"23","author":"Holzer","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0240","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/mmr.2014.2040","article-title":"Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer\u2019s disease (review)","volume":"9","author":"Cai","year":"2014","journal-title":"Mol Med Rep"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130305_bb0245","first-page":"951","article-title":"Mood and sleep changes with monoamine-oxidase inhibitors","volume":"66","author":"Dunleavy","year":"1973","journal-title":"Proc R Soc Med"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuint.2012.12.014","article-title":"Effect of diet on serotonergic neurotransmission in depression","volume":"62","author":"Shabbir","year":"2013","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130305_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0006-3223(95)00077-1","article-title":"Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression","volume":"38","author":"Merikangas","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-1781(94)02555-W","article-title":"Platelet monoamine oxidase activity and deficit syndrome schizophrenia","volume":"56","author":"Samson","year":"1995","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0265","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.psychres.2009.08.013","article-title":"Platelet monoamine oxidase activity in children with attention-deficit\/hyperactivity disorder","volume":"175","author":"Nedic","year":"2010","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0270","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00702-004-0108-0","article-title":"Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine","volume":"111","author":"Marziniak","year":"2004","journal-title":"J Neural Transm"},{"issue":"10\u221211","key":"10.1016\/j.bmcl.2025.130305_bb0275","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00702-004-0143-x","article-title":"Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson\u2019s disease and other neurodegenerative diseases","volume":"111","author":"Youdim","year":"2004","journal-title":"J Neural Transm"},{"issue":"36","key":"10.1016\/j.bmcl.2025.130305_bb0280","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B","volume":"102","author":"De Colibus","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0304-3940(02)00307-5","article-title":"Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer\u2019s disease patients","volume":"326","author":"Emilsson","year":"2002","journal-title":"Neurosci Lett"},{"issue":"19","key":"10.1016\/j.bmcl.2025.130305_bb0290","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1021\/jm300978h","article-title":"Multitarget-directed benzylideneindanone derivatives: anti-\u03b2-amyloid (a\u03b2) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer\u2019s disease","volume":"55","author":"Huang","year":"2012","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0295","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/138955712800493898","article-title":"From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A\/B","volume":"12","author":"Zheng","year":"2012","journal-title":"Mini-Rev Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0300","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00441-003-0765-6","article-title":"A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues","volume":"313","author":"Sivasubramaniam","year":"2003","journal-title":"Cell Tissue Res"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0305","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/mp.2016.127","article-title":"The significance of selegiline\/(\u2212)-deprenyl after 50 years in research and therapy (1965-2015)","volume":"21","author":"Miklya","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer\u2019s disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0315","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1039\/C9MD00337A","article-title":"Current and emerging therapeutic targets of alzheimer\u2019s disease for the design of multi-target directed ligands","volume":"10","author":"Blaikie","year":"2019","journal-title":"MedChemComm"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/oxfordjournals.bmb.a072632","article-title":"Free radicals in brain metabolism and pathology","volume":"49","author":"Evans","year":"1993","journal-title":"Br Med Bull"},{"issue":"33","key":"10.1016\/j.bmcl.2025.130305_bb0325","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","article-title":"Protein oxidation in aging, disease, and oxidative stress","volume":"272","author":"Berlett","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/nu9010029","article-title":"Coenzyme Q10 and oxidative stress: inflammation status in hepatocellular carcinoma patients after surgery","volume":"9","author":"Liu","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.bmcl.2025.130305_bb0335","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fnins.2018.00632","article-title":"Iron and Alzheimer\u2019s disease: from pathogenesis to therapeutic implications","volume":"12","author":"Liu","year":"2018","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0340","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer\u2019s disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0345","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/jf021156g","article-title":"Antioxidant activity of peptides obtained from porcine Myofibrillar proteins by protease treatment","volume":"51","author":"Saiga","year":"2003","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0350","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmcl.2025.130305_bb0355","doi-asserted-by":"crossref","unstructured":"Eckroat TJ, Manross DL, Cowan SC. Merged Tacrine-Based, Multitarget-directed acetylcholinesterase inhibitors 2015-present: synthesis and biological activity. Int J Mol Sci 2020;21(17). DOI:https:\/\/doi.org\/10.3390\/ijms21175965.","DOI":"10.3390\/ijms21175965"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(99)00741-4","article-title":"Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats","volume":"386","author":"Kosasa","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"17","key":"10.1016\/j.bmcl.2025.130305_bb0365","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1021\/jm00043a012","article-title":"Novel Benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase","volume":"37","author":"Villalobos","year":"1994","journal-title":"J Med Chem"},{"issue":"25","key":"10.1016\/j.bmcl.2025.130305_bb0370","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.2174\/1381612043383359","article-title":"An overview of the current and novel drugs for Alzheimer\u2019s disease with particular reference to anti-cholinesterase compounds","volume":"10","author":"Colombres","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0375","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/ern.09.23","article-title":"Donepezil in the treatment of patients with Alzheimer\u2019s disease","volume":"9","author":"Tsuno","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0380","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00004714-199912000-00005","article-title":"Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans","volume":"19","author":"Kennedy","year":"1999","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0385","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0149-2918(98)80127-6","article-title":"Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer\u2019s disease","volume":"20","author":"Polinsky","year":"1998","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0390","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2165\/00003495-200060050-00008","article-title":"Galantamine: a review of its use in Alzheimer\u2019s disease","volume":"60","author":"Scott","year":"2000","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0395","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-4328(00)00214-X","article-title":"Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer\u2019s disease","volume":"113","author":"Maelicke","year":"2000","journal-title":"Behav Brain Res"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb0400","article-title":"Synthesis of new Quinoline-Piperonal hybrids as potential drugs against Alzheimer\u2019s disease","volume":"20","author":"de Oliveira","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130305_bb0405","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.compbiolchem.2018.04.003","article-title":"In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors","volume":"74","author":"Begum","year":"2018","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130305_bb0410","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejmech.2016.10.042","article-title":"Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes","volume":"124","author":"Sa\u011fl\u0131k","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10989-022-10472-4","article-title":"Biological characterization of natural peptide BcI-1003 from Boana cordobae (anura): role in Alzheimer\u2019s disease and microbial infections","volume":"29","author":"Spinelli","year":"2022","journal-title":"Int J Pept Res Ther"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb0420","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4155\/fmc.09.113","article-title":"Natural product scaffolds as leads to drugs","volume":"1","author":"Newman","year":"2009","journal-title":"Future Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0425","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0430","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwac206","article-title":"Natural products and drug discovery","volume":"9","author":"Newman","year":"2022","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.bmcl.2025.130305_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103162","article-title":"Something \u201cold, new, borrowed, or blue\u201d, the search for mother nature\u2019s bioactive agents","volume":"88","author":"Newman","year":"2024","journal-title":"Curr Opin Biotechnol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0440","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4155\/fmc.12.94","article-title":"Therapeutic peptides","volume":"4","author":"Albericio","year":"2012","journal-title":"Future Med Chem"},{"issue":"17\u201318","key":"10.1016\/j.bmcl.2025.130305_bb0445","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0450","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/molecules23030533","article-title":"The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules","volume":"23","author":"de la Torre","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130305_bb0455","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.0105-2896.2004.0124.x","article-title":"Anti-microbial peptides: from invertebrates to vertebrates","volume":"198","author":"Bulet","year":"2004","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130305_bb0460","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/molecules23092344","article-title":"Natural peptides in drug discovery targeting acetylcholinesterase","volume":"23","author":"Prasasty","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1163\/157075407779766741","article-title":"How frogs and humans interact: influences beyond habitat destruction, epidemics and global warming","volume":"4","author":"Tyler","year":"2007","journal-title":"Appl Herpetol"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb0470","first-page":"579","article-title":"Bioactive molecules from amphibian skin: their biological activities with reference to therapeutic potentials for possible drug development","volume":"45","author":"Gomes","year":"2007","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.bmcl.2025.130305_bb0475","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.peptides.2014.04.019","article-title":"Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents","volume":"57","author":"Conlon","year":"2014","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0480","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/1056-8719(92)90004-K","article-title":"A novel method for the release and collection of dermal, glandular secretions from the skin of frogs","volume":"28","author":"Tyler","year":"1992","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0485","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/np4009317","article-title":"Antimicrobial peptides from skin secretions of Hypsiboas pulchellus (Anura: Hylidae)","volume":"77","author":"Siano","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2025.130305_bb0490","first-page":"128","article-title":"A comparative study of the biological activity of skin and granular gland secretions of Leptodactylus latrans and Hypsiboas pulchellus from Argentina","volume":"8","author":"Siano","year":"2014","journal-title":"Rec Nat Prod"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0495","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00726-019-02815-1","article-title":"Acetylcholinesterase inhibitory activity of a naturally occurring peptide isolated from Boana pulchella (Anura: Hylidae) and its analogs","volume":"52","author":"Sanchis","year":"2020","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800472","article-title":"Natural multi-target inhibitors of Cholinesterases and monoamine oxidase enzymes with antioxidant potential from skin extracts of Hypsiboas cordobae and Pseudis minuta (Anura: Hylidae)","volume":"16","author":"Spinelli","year":"2019","journal-title":"Chem Biodivers"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130305_bb0505","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1021\/bi051847g","article-title":"Functional role of the \u201caromatic cage\u201d in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130305_bb0510","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.freeradbiomed.2010.01.036","article-title":"Frog skins keep redox homeostasis by antioxidant peptides with rapid radical scavenging ability","volume":"48","author":"Liu","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0515","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/abbs\/gmx032","article-title":"Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four east Asian frog species","volume":"49","author":"Wang","year":"2017","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0520","first-page":"571","article-title":"Antioxidant peptidomics reveals novel skin antioxidant system","volume":"8","author":"Yang","year":"2009","journal-title":"MCP"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0525","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/14786419.2019.1591396","article-title":"Amphibian skin extracts as source of bioactive multi-target agents against different pathways of Alzheimer\u2019s disease","volume":"35","author":"Spinelli","year":"2021","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2025.130305_bb0530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.toxicon.2020.01.008","article-title":"Cytotoxic and antiproliferative activities of amphibian (anuran) skin extracts on human acute monocytic leukemia cells","volume":"177","author":"Spinelli","year":"2020","journal-title":"Toxicon\u202f: official J Int Soc Toxinol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0535","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1080\/14786419.2021.1953022","article-title":"Natural multi-target modulators of pathological pathways in Alzheimer\u2019s disease isolated from the Rhinella arenarum skin","volume":"36","author":"Spinelli","year":"2021","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2025.130305_bb0540","series-title":"Handbook of Biologically Active Peptides","first-page":"283","article-title":"CHAPTER 43 - host defense peptides from Australian amphibians: Caerulein and other neuropeptides","author":"Bowie","year":"2006"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0545","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0192623313486967","article-title":"Autophagy in pancreatic acinar cells in caerulein-treated mice: immunolocalization of related proteins and their potential as markers of pancreatitis","volume":"42","author":"Zhang","year":"2014","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.bmcl.2025.130305_bb0550","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.npep.2017.11.010","article-title":"Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer\u2019s disease","volume":"67","author":"Camargo","year":"2018","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0555","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0197-0186(83)90028-1","article-title":"Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom","volume":"5","author":"Rodriguez-Ithurralde","year":"1983","journal-title":"Neurochem Int"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0560","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s002100000382","article-title":"Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors","volume":"363","author":"Lockhart","year":"2001","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb0565","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1074\/jbc.M006855200","article-title":"Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex","volume":"276","author":"Radi\u0107","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130305_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.108164","article-title":"Bee venom and melittin: potent key enzyme inhibitors with promising therapeutic potential","volume":"252","author":"Alparslan","year":"2024","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0575","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2004.09.009","article-title":"Monoamine oxidase inhibitory activities of the scorpion Mesobuthus gibbosus (Buthidae) venom peptides","volume":"45","author":"Ucar","year":"2005","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb0580","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/1533317513500839","article-title":"Antioxidant and cholinesterase inhibitory activity of a new peptide from Ziziphus jujuba fruits","volume":"28","author":"Zare-Zardini","year":"2013","journal-title":"Am J Alzheimers Dis Other Dement"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0585","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11746-015-2779-0","article-title":"In vitro acetylcholinesterase-inhibitory properties of enzymatic hemp seed protein hydrolysates","volume":"93","author":"Malomo","year":"2016","journal-title":"JAOCS"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0590","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jfda.2014.05.006","article-title":"Finding of polysaccharide-peptide complexes in Cordyceps militaris and evaluation of its acetylcholinesterase inhibition activity","volume":"23","author":"Tsai","year":"2015","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.bmcl.2025.130305_bb0595","first-page":"3","article-title":"Peptides derived from rice bran protect cells from obesity and Alzheimer\u2019s disease","author":"Kannan","year":"2012","journal-title":"Int J Biomed Res"},{"key":"10.1016\/j.bmcl.2025.130305_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.950823","article-title":"The current research status and strategies employed to modify food-derived bioactive peptides","volume":"9","author":"Majura","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0605","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2005.11.004","article-title":"Cationic host defense (antimicrobial) peptides","volume":"18","author":"Brown","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.bmcl.2025.130305_bb0610","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-009-0172-8","article-title":"The effect of C-terminal amidation on the efficacy and selectivity of antimicrobial and anticancer peptides","volume":"332","author":"Dennison","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"Suppl1","key":"10.1016\/j.bmcl.2025.130305_bb0615","first-page":"157","article-title":"Effect of amino acid substitutions on biological activity of antimicrobial peptide: design, recombinant production, and biological activity","volume":"18","author":"Panahi Chegini","year":"2019","journal-title":"Iran J Pharm Res: IJPR"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0620","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00726-021-03096-3","article-title":"Rational design and synthesis of modified natural peptides from Boana pulchella (anura) as acetylcholinesterase inhibitors and antioxidants","volume":"54","author":"Sanchis","year":"2022","journal-title":"Amino Acids"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0625","article-title":"Inhibition of human Cholinesterases and in vitro \u03b2-amyloid aggregation by rationally designed peptides","volume":"18","author":"Sanchis","year":"2023","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0630","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acsbiomedchemau.2c00067","article-title":"Controlling amyloid Beta peptide aggregation and toxicity by protease-stable ligands","volume":"3","author":"Mallesh","year":"2023","journal-title":"ACS Bio Med Chem Au"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0635","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cimb44010004","article-title":"Lessons from a single amino acid substitution: anticancer and antibacterial properties of two phospholipase A(2)-derived peptides","volume":"44","author":"Almeida","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.bmcl.2025.130305_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2025.113120","article-title":"Single amino acid substitution analogs of marine antioxidant peptides with membrane permeability exert a marked protective effect against ultraviolet-B induced damage","volume":"264","author":"Huang","year":"2025","journal-title":"J Photochem Photobiol B"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130305_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/nu15102373","article-title":"Alanine substitution to determine the effect of LR5 and YR6 Rice peptide structure on antioxidant and anti-inflammatory activity","volume":"15","author":"Cheng","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130305_bb0650","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/01.STR.0000242772.94277.1f","article-title":"Humanin is a novel neuroprotective agent against stroke","volume":"37","author":"Xu","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bmcl.2025.130305_bb0655","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lfs.2017.05.014","article-title":"Protective roles of bioactive peptides during ischemia-reperfusion injury: from bench to bedside","volume":"180","author":"Wu","year":"2017","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0660","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae583","article-title":"ToxGIN: an in silico prediction model for peptide toxicity via graph isomorphism networks integrating peptide sequence and structure information","volume":"25","author":"Yu","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.bmcl.2025.130305_bb0665","first-page":"1538","article-title":"ToxDL 2.0: protein toxicity prediction using a pretrained language model and graph neural networks. Comput Struct","volume":"27","author":"Zhu","year":"2025","journal-title":"Biotechnol J"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030323","article-title":"Traditional and computational screening of non-toxic peptides and approaches to improving selectivity","volume":"15","author":"Robles-Loaiza","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2025.130305_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108926","article-title":"ToxinPred 3.0: an improved method for predicting the toxicity of peptides","volume":"179","author":"Rathore","year":"2024","journal-title":"Comput Biol Med"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0680","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1021\/acsbiomaterials.0c01010","article-title":"Machine learning-based amino acid substitution of short peptides: Acquisition of Peptides with enhanced inhibitory activities against \u03b1-amylase and \u03b1-glucosidase","volume":"6","author":"Yamashita","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"issue":"17","key":"10.1016\/j.bmcl.2025.130305_bb0685","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713110","article-title":"Advances in Alzheimer\u2019s disease-associated a\u03b2 therapy based on peptide","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/ph16070996","article-title":"Cyclic peptides in pipeline: what future for these great molecules?","volume":"16","author":"Costa","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb0695","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1039\/C5SC01774B","article-title":"Spontaneous head-to-tail cyclization of unprotected linear peptides with the KAHA ligation","volume":"6","author":"Rohrbacher","year":"2015","journal-title":"Chem Sci"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0700","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1039\/D3CC04630C","article-title":"Unlocking novel therapies: cyclic peptide design for amyloidogenic targets through synergies of experiments, simulations, and machine learning","volume":"60","author":"de Raffele","year":"2024","journal-title":"Chem Commun (Camb)"},{"issue":"17","key":"10.1016\/j.bmcl.2025.130305_bb0705","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cbic.201402430","article-title":"A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-\u03b2 oligomers","volume":"15","author":"Arai","year":"2014","journal-title":"Chembiochem"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130305_bb0710","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.bmcl.2015.05.027","article-title":"Covalent modifier-type aggregation inhibitor of amyloid-\u03b2 based on a cyclo-KLVFF motif","volume":"25","author":"Kino","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0715","doi-asserted-by":"crossref","first-page":"15280","DOI":"10.1038\/s41598-020-69626-3","article-title":"A rationally designed bicyclic peptide remodels A\u03b242 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer\u2019s disease","volume":"10","author":"Ikenoue","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0720","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.1c00033","article-title":"Disulfide-rich cyclic peptides from Clitoria ternatea protect against \u03b2-amyloid toxicity and oxidative stress in transgenic Caenorhabditis elegans","volume":"64","author":"Kalmankar","year":"2021","journal-title":"J Med Chem"},{"issue":"44","key":"10.1016\/j.bmcl.2025.130305_bb0725","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1002\/anie.201802979","article-title":"Designed macrocyclic peptides as Nanomolar amyloid inhibitors based on minimal recognition elements","volume":"57","author":"Spanopoulou","year":"2018","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.bmcl.2025.130305_bb0730","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejmech.2016.01.006","article-title":"Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold","volume":"109","author":"Wang","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"42","key":"10.1016\/j.bmcl.2025.130305_bb0735","doi-asserted-by":"crossref","first-page":"23131","DOI":"10.1021\/jacs.3c06830","article-title":"\u0392-Bracelets: macrocyclic cross-\u03b2 epitope mimics based on a tau conformational strain","volume":"145","author":"Rajewski","year":"2023","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0740","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300320","article-title":"A RaPID macrocyclic peptide that inhibits the formation of \u03b1-Synuclein amyloid fibrils","volume":"24","author":"Ikenoue","year":"2023","journal-title":"Chembiochem"},{"issue":"40","key":"10.1016\/j.bmcl.2025.130305_bb0745","doi-asserted-by":"crossref","first-page":"14236","DOI":"10.1002\/chem.201601830","article-title":"Self-Assembled Cyclic d,l-\u03b1-Peptides as Generic Conformational Inhibitors of the \u03b1-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies","volume":"22","author":"Chemerovski-Glikman","year":"2016","journal-title":"Chemistry"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130305_bb0750","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1021\/acschemneuro.3c00589","article-title":"Cyclization of peptides enhances the inhibitory activity against ganglioside-induced a\u03b2 fibril formation","volume":"14","author":"Miyamoto","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"41","key":"10.1016\/j.bmcl.2025.130305_bb0755","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1074\/jbc.RA118.003116","article-title":"A d-enantiomeric peptide interferes with heteroassociation of amyloid-\u03b2 oligomers and prion protein","volume":"293","author":"R\u00f6sener","year":"2018","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126553","article-title":"In vitro and in vivo efficacies of the linear and the cyclic version of an all-d-enantiomeric peptide developed for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Schemmert","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"49","key":"10.1016\/j.bmcl.2025.130305_bb0765","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210766119","article-title":"Early diagnosis and treatment of Alzheimer\u2019s disease by targeting toxic soluble a\u03b2 oligomers","volume":"119","author":"Habashi","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200537","article-title":"D-peptide and D-protein technology: recent advances, challenges, and opportunities","volume":"24","author":"Lander","year":"2023","journal-title":"Chembiochem"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168677","article-title":"Recent applications of retro-Inverso peptides","volume":"22","author":"Doti","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0780","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1002\/alz.14246","article-title":"A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer\u2019s disease and other tauopathies","volume":"20","author":"Aggidis","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb0785","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/bi701415b","article-title":"Designing peptide inhibitors for oligomerization and toxicity of Alzheimer\u2019s beta-amyloid peptide","volume":"47","author":"Austen","year":"2008","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0790","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/ADR-190107","article-title":"Pre-clinical safety and efficacy evaluation of Amytrap, a novel therapeutic to treat Alzheimer\u2019s disease","volume":"3","author":"Gandbhir","year":"2019","journal-title":"J Alzheimers Dis Rep"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0795","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0800","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013863","article-title":"Inhibiting \u03b1-synuclein oligomerization by stable cell-penetrating \u03b2-synuclein fragments recovers phenotype of Parkinson\u2019s disease model flies","volume":"5","author":"Shaltiel-Karyo","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130305_bb0805","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/mp500086e","article-title":"Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery","volume":"11","author":"Wei","year":"2014","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0810","first-page":"12896","article-title":"Small peptides targeting BACE-1, AChE, and A-\u03b2 reversing scopolamine-induced memory impairment: A multitarget approach against Alzheimer\u2019s disease","volume":"9","author":"Kaur","year":"2024","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0815","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbamem.2015.01.014","article-title":"The role of C-terminal amidation in the membrane interactions of the anionic antimicrobial peptide, maximin H5","volume":"1848","author":"Dennison","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0820","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-2010-1297","article-title":"LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity","volume":"19","author":"Granic","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb0825","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.M113.537472","article-title":"Computational and experimental studies on \u03b2-sheet breakers targeting A\u03b21-40 fibrils","volume":"289","author":"Minicozzi","year":"2014","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130305_bb0830","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/bi100144m","article-title":"Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer\u2019s disease","volume":"49","author":"Taylor","year":"2010","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0835","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45437-0","article-title":"Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin","volume":"13","author":"D\u2019Accolti","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0840","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.1038\/s41598-021-95255-5","article-title":"Acetylation turns leucine into a drug by membrane transporter switching","volume":"11","author":"Churchill","year":"2021","journal-title":"Sci Rep"},{"issue":"17\u201318","key":"10.1016\/j.bmcl.2025.130305_bb0845","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0161-5890(95)00103-4","article-title":"Fine chemical modifications at N- and C-termini enhance peptide presentation to T cells by increasing the lifespan of both free and MHC-complexed peptides","volume":"32","author":"Maill\u00e8re","year":"1995","journal-title":"Mol Immunol"},{"issue":"24","key":"10.1016\/j.bmcl.2025.130305_bb0850","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1021\/jm901092h","article-title":"Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster","volume":"52","author":"Pratim Bose","year":"2009","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb0855","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/cmdc.200800273","article-title":"Reduction of Alzheimer\u2019s disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display","volume":"3","author":"van Groen","year":"2008","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0860","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1568026024607508","article-title":"Peptide inhibitors of beta amyloid aggregation","volume":"2","author":"Findeis","year":"2002","journal-title":"Curr Top Med Chem"},{"issue":"30","key":"10.1016\/j.bmcl.2025.130305_bb0865","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1021\/ja5049626","article-title":"Chiral effect at protein\/graphene interface: a bioinspired perspective to understand amyloid formation","volume":"136","author":"Qing","year":"2014","journal-title":"J Am Chem Soc"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130305_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115676","article-title":"Design and synthesis of \u03b2-strand-fixed peptides inhibiting aggregation of amyloid \u03b2-protein","volume":"28","author":"Tanaka","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130305_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170666","article-title":"Chemical modifications to increase the therapeutic potential of antimicrobial peptides","volume":"146","author":"Han","year":"2021","journal-title":"Peptides"},{"issue":"42","key":"10.1016\/j.bmcl.2025.130305_bb0880","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1021\/bi300415v","article-title":"The N-methylated peptide SEN304 powerfully inhibits a\u03b2(1-42) toxicity by perturbing oligomer formation","volume":"51","author":"Amijee","year":"2012","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb0885","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/bip.21151","article-title":"Rationally designed dehydroalanine (\u0394Ala)-containing peptides inhibit amyloid-\u03b2 (a\u03b2) peptide aggregation","volume":"91","author":"Rangachari","year":"2009","journal-title":"Biopolymers"},{"key":"10.1016\/j.bmcl.2025.130305_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116474","article-title":"Unveiling the inhibitory mechanism of peptidomimetic inhibitor against A\u03b242 aggregation and protofibril disaggregation by molecular dynamics","volume":"335","author":"Kaur","year":"2021","journal-title":"J Mol Liq"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb0895","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s42003-023-05254-7","article-title":"Molecular hybridization strategy for tuning bioactive peptide function","volume":"6","author":"Pedron","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.bmcl.2025.130305_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110092","article-title":"Kinetic and structural studies on the inhibition of acetylcholinesterase and butyrylcholinesterase by a series of multitarget-directed galantamine-peptide derivatives","volume":"365","author":"Pesaresi","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130305_bb0905","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3233\/JAD-210577","article-title":"New Galantamine derivatives with inhibitory effect on acetylcholinesterase activity","volume":"83","author":"Lazarova","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130305_bb0910","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/smll.201202612","article-title":"Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid \u03b2-peptide aggregation associated with Alzheimer\u2019s disease","volume":"9","author":"Li","year":"2013","journal-title":"Small"},{"issue":"1\u20132","key":"10.1016\/j.bmcl.2025.130305_bb0915","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2018.10.022","article-title":"Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma","volume":"553","author":"Di Mauro","year":"2018","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb0920","article-title":"Rational fusion design inspired by cell-penetrating peptide: SS31\/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Qian","year":"2024","journal-title":"Asian J Pharm Sci"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb0925","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.peptides.2009.04.012","article-title":"Hybrid peptides attenuate cytotoxicity of beta-amyloid by inhibiting its oligomerization: implication from solvent effects","volume":"30","author":"Sun","year":"2009","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb0930","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1021\/am501341u","article-title":"Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-\u03b2 aggregation and cytotoxicity","volume":"6","author":"Zhang","year":"2014","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130305_bb0935","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1021\/acsami.5b00915","article-title":"Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid \u03b2-protein fibrillation and cytotoxicity","volume":"7","author":"Xiong","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"issue":"13","key":"10.1016\/j.bmcl.2025.130305_bb0940","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201601666","article-title":"Design of a Molecular Hybrid of dual peptide inhibitors coupled on AuNPs for enhanced inhibition of amyloid \u03b2-protein aggregation and cytotoxicity","volume":"13","author":"Xiong","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.bmcl.2025.130305_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116070","article-title":"Curcumin hybrid molecules for the treatment of Alzheimer\u2019s disease: structure and pharmacological activities","volume":"265","author":"Zang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130305_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177274","article-title":"Memantine and amantadine KLVFF peptide conjugates: synthesis, structure determination, amyloid-\u03b2 interaction and effects on recognition memory in mice","volume":"990","author":"Bocchieri","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb0955","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cbic.201600243","article-title":"Ac-LPFFD-Th: A Trehalose-conjugated Peptidomimetic as a strong suppressor of amyloid-\u03b2 oligomer formation and cytotoxicity","volume":"17","author":"Sinopoli","year":"2016","journal-title":"Chembiochem"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb0960","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24083","article-title":"Potential therapeutics of Alzheimer\u2019s diseases: new insights into the neuroprotective role of trehalose-conjugated beta sheet breaker peptides","volume":"110","author":"Di Natale","year":"2018","journal-title":"Pept Sci"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130305_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400431","article-title":"A spectroscopic study on the amyloid-\u03b2 interaction with clicked peptide-porphyrin conjugates: a vision toward the detection of a\u03b2 peptides in aqueous solution","volume":"25","author":"Tosto","year":"2024","journal-title":"Chembiochem"},{"issue":"28","key":"10.1016\/j.bmcl.2025.130305_bb0970","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1002\/slct.201701148","article-title":"A Metalloporphyrin-peptide conjugate as an effective inhibitor of amyloid-\u03b2 peptide fibrillation and cytotoxicity","volume":"2","author":"Villari","year":"2017","journal-title":"ChemistrySelect"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb0975","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acschemneuro.1c00117","article-title":"Novel peptide-calix[4]arene conjugate inhibits a\u03b2 aggregation and rescues neurons from a\u03b2\u2019s oligomers cytotoxicity in vitro","volume":"12","author":"Consoli","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmcl.2025.130305_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113326","article-title":"Hybrid peptides as platform for synchronized combination therapy","volume":"226","author":"Ashrafichoobdar","year":"2023","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb0985","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13346-023-01410-y","article-title":"Self-assembled peptide\/polymer hybrid nanoplatform for cancer immunostimulating therapies","volume":"14","author":"Khazaei","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.bmcl.2025.130305_bb0990","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S123422","article-title":"Angiopep-2-conjugated poly(ethylene glycol)-co- poly(\u03b5-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats","volume":"12","author":"Lu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.bmcl.2025.130305_bb0995","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nano.2018.09.010","article-title":"Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer\u2019s disease brain","volume":"16","author":"Ahlschwede","year":"2019","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb1000","doi-asserted-by":"crossref","DOI":"10.1088\/2632-959X\/ab9008","article-title":"Peptide based drug delivery systems to the brain","volume":"1","author":"Islam","year":"2020","journal-title":"Nano Express"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb1005","first-page":"595","article-title":"The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems","volume":"14","author":"Lu","year":"2019","journal-title":"Asian J Pharm Sci"},{"issue":"44","key":"10.1016\/j.bmcl.2025.130305_bb1010","doi-asserted-by":"crossref","first-page":"29977","DOI":"10.1021\/acsami.6b10146","article-title":"Liposome-based systemic glioma-targeted drug delivery enabled by all-d peptides","volume":"8","author":"Ying","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"issue":"31","key":"10.1016\/j.bmcl.2025.130305_bb1015","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1021\/bi060264j","article-title":"Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand","volume":"45","author":"Kim","year":"2006","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb1020","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.2c00523","article-title":"Peptides as pharmacological carriers to the brain: promises","volume":"19","author":"Parrasia","year":"2022","journal-title":"Shortcomings and Challenges Mol Pharm"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb1025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jgm.1062","article-title":"Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine)","volume":"9","author":"Park","year":"2007","journal-title":"J Gene Med"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004786","article-title":"Effective Design of Multifunctional Peptides by combining compatible functions","volume":"12","author":"Diener","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb1035","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1021\/bi0524868","article-title":"Flexibility and plasticity of human centrin 2 binding to the xeroderma pigmentosum group C protein (XPC) from nuclear excision repair","volume":"45","author":"Yang","year":"2006","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130305_bb1040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189752","article-title":"The central PXXP motif is crucial for PMAP-23 translocation across the lipid bilayer","volume":"22","author":"Yang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb1045","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1038\/s41598-022-08247-4","article-title":"A novel hybrid peptide composed of LfcinB6 and KR-12-a4 with enhanced antimicrobial, anti-inflammatory and anti-biofilm activities","volume":"12","author":"Ajish","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130305_bb1050","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/med.21720","article-title":"Making smart drugs smarter: the importance of linker chemistry in targeted drug delivery","volume":"40","author":"Yang","year":"2020","journal-title":"Med Res Rev"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb1055","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s10989-020-10054-2","article-title":"Augmenting peptide flexibility by inserting gamma-aminobutyric acid (GABA) in their sequence","volume":"26","author":"Shahabi","year":"2020","journal-title":"Int J Pept Res Ther"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130305_bb1060","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1016\/j.bmcl.2013.08.075","article-title":"Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides","volume":"23","author":"Guo","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130305_bb1065","doi-asserted-by":"crossref","first-page":"614","DOI":"10.37349\/eds.2024.00064","article-title":"Hybrid peptides inspired by the RWQWRWQWR sequence inhibit cervical cancer cells growth in vitro","volume":"2","author":"Ardila-Chantr\u00e9","year":"2024","journal-title":"Exploration of Drug Science"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb1070","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1021\/jacs.6b09734","article-title":"\u0391-Helix mimetics as modulators of a\u03b2 self-assembly","volume":"139","author":"Kumar","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"19","key":"10.1016\/j.bmcl.2025.130305_bb1075","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1039\/D4SC01540A","article-title":"A high-resolution structural characterization and physicochemical study of how a peptoid binds to an oncoprotein MDM2","volume":"15","author":"Yokomine","year":"2024","journal-title":"Chem Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb1080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bmc.2016.10.007","article-title":"Modulating amyloid-\u03b2 aggregation: the effects of peptoid side chain placement and chirality","volume":"25","author":"Turner","year":"2017","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb1085","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1039\/b817980h","article-title":"Structure\u2013function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function","volume":"7","author":"Fowler","year":"2009","journal-title":"Org Biomol Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130305_bb1090","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acschemneuro.8b00071","article-title":"Genesis of neuroprotective Peptoid from A\u03b230-34 inhibits a\u03b2 aggregation and AChE activity","volume":"9","author":"Pradhan","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130305_bb1095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/acschemneuro.2c00549","article-title":"Short Peptoid evolved from the key hydrophobic stretch of amyloid-\u03b242 peptide serves as a potent therapeutic Lead of Alzheimer\u2019s disease","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"45","key":"10.1016\/j.bmcl.2025.130305_bb1100","doi-asserted-by":"crossref","first-page":"18855","DOI":"10.1039\/D4SC04313H","article-title":"A cocktail of Cu2+\u2212 and Zn2+\u2212peptoid-based chelators can stop ROS formation for Alzheimer\u2019s disease therapy","volume":"15","author":"Behar","year":"2024","journal-title":"Chem Sci"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130305_bb1105","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1002\/prot.22851","article-title":"Structure-based prediction of protein\u2013peptide specificity in rosetta","volume":"78","author":"King","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.bmcl.2025.130305_bb1110","series-title":"Methods Enzymol","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/B978-0-12-381270-4.00019-6","article-title":"Chapter nineteen - Rosetta3: An object-oriented software suite for the simulation and design of macromolecules","volume":"Vol. 487","author":"Leaver-Fay","year":"2011"},{"key":"10.1016\/j.bmcl.2025.130305_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108202","article-title":"Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides","volume":"156","author":"Sanchis","year":"2025","journal-title":"Bioorg Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb1120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/acscentsci.3c00364","article-title":"Stretching peptides\u2019 potential to target protein-protein interactions","volume":"9","author":"Venneti","year":"2023","journal-title":"ACS Cent Sci"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb1125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-024-01578-5","article-title":"Design of amyloidogenic peptide traps","volume":"20","author":"Sahtoe","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"34","key":"10.1016\/j.bmcl.2025.130305_bb1130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206240119","article-title":"De novo designed protein inhibitors of amyloid aggregation and seeding","volume":"119","author":"Murray","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.bmcl.2025.130305_bb1135","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1039\/D3SC06245G","article-title":"De novo design of peptides that bind specific conformers of \u03b1-synuclein","volume":"15","author":"Wallace","year":"2024","journal-title":"Chem Sci"},{"issue":"W1","key":"10.1016\/j.bmcl.2025.130305_bb1140","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkw366","article-title":"PepComposer: computational design of peptides binding to a given protein surface","volume":"44","author":"Obarska-Kosinska","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130305_bb1145","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1093\/bioinformatics\/btr498","article-title":"PepCrawler: a fast RRT-based algorithm for high-resolution refinement and binding affinity estimation of peptide inhibitors","volume":"27","author":"Donsky","year":"2011","journal-title":"Bioinformatics"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130305_bb1150","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/bioinformatics\/btw133","article-title":"PinaColada: peptide-inhibitor ant colony ad-hoc design algorithm","volume":"32","author":"Zaidman","year":"2016","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130305_bb1155","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/prot.26384","article-title":"Pep-whisperer: inhibitory peptide design","volume":"90","author":"Hurwitz","year":"2022","journal-title":"Proteins"},{"issue":"7976","key":"10.1016\/j.bmcl.2025.130305_bb1160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb1165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s42004-023-01029-7","article-title":"Peptide binder design with inverse folding and protein structure prediction","volume":"6","author":"Bryant","year":"2023","journal-title":"Commun Chem"},{"key":"10.1016\/j.bmcl.2025.130305_bb1170","article-title":"Atomic context-conditioned protein sequence design using LigandMPNN","author":"Dauparas","year":"2023","journal-title":"Nat Methods"},{"issue":"6615","key":"10.1016\/j.bmcl.2025.130305_bb1175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.add2187","article-title":"Robust deep learning-based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130305_bb1180","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41467-024-45051-2","article-title":"Protein structure generation via folding diffusion","volume":"15","author":"Wu","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130305_bb1185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tips.2023.04.003","article-title":"Recent advances in the development of therapeutic peptides","volume":"44","author":"Fetse","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130305_bb1190","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00044-024-03269-1","article-title":"Peptide-based therapeutics: challenges and solutions","volume":"33","author":"Pereira","year":"2024","journal-title":"Med Chem Res"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130305_bb1195","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1039\/C7CS00536A","article-title":"Molecular engineering solutions for therapeutic peptide delivery","volume":"46","author":"Acar","year":"2017","journal-title":"Chem Soc Rev"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130305_bb1200","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like Peptide-1 (GLP-1) analogue Semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130305_bb1205","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/med.21658","article-title":"Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening","volume":"40","author":"Basith","year":"2020","journal-title":"Med Res Rev"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:21:37Z","timestamp":1752600097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25002148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":241,"alternative-id":["S0960894X25002148"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130305","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fighting Alzheimer's naturally: Peptides as multitarget drug leads","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130305"}}